Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.

Chao S, Roberts JS, Marteau TM, Silliman R, Cupples LA, Green RC.

Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):94-7. doi: 10.1097/WAD.0b013e31815a9dcc.

2.

Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.

Schipper HM.

Alzheimers Dement. 2011 Jul;7(4):e118-23. doi: 10.1016/j.jalz.2010.06.003. Epub 2011 Jun 14. Review.

PMID:
21665554
4.

Alzheimer's disease: clinical implications of the apolipoprotein E genotype.

Farlow MR.

Neurology. 1997 May;48(5 Suppl 6):S30-4. Review.

PMID:
9153158
5.
6.

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.

Roberts JS, Christensen KD, Green RC.

Clin Genet. 2011 Nov;80(5):407-14. doi: 10.1111/j.1399-0004.2011.01739.x. Epub 2011 Jul 18. Review.

7.

Evaluation of genetic tests: APOE genotyping for the diagnosis of Alzheimer disease.

McConnell LM, Sanders GD, Owens DK.

Genet Test. 1999;3(1):47-53. Review.

PMID:
10464577
8.

Impact of genetic risk assessment on nutrition-related lifestyle behaviours.

Vernarelli JA.

Proc Nutr Soc. 2013 Feb;72(1):153-9. doi: 10.1017/S0029665112002741. Epub 2012 Oct 25. Review.

Supplemental Content

Support Center